Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.3 USD | -0.17% | -1.05% | +16.51% |
01:25pm | Nephron Research Raises Boston Scientific's Price Target to $80 From $75 | MT |
Apr. 17 | FDA classifies recall of Boston Scientific device as 'most serious' | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.51% | 99.1B | |
+2.49% | 207B | |
+1.56% | 175B | |
+8.38% | 132B | |
-3.42% | 60.89B | |
+12.52% | 52.04B | |
-6.61% | 45.48B | |
-4.71% | 38.81B | |
+9.13% | 38.77B | |
+3.28% | 26.09B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Boston Scientific Starts Clinical Trial of Modular Cardiac Rhythm Management Therapy System